B. Janardhanam
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 8
- HIV/AIDS drug development and treatment 1
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 1
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Mycobacterium research and diagnosis 3
-
- Infectious Diseases and Tuberculosis 1
-
- Biochemical and Molecular Research 2
- Cancer therapeutics and mechanisms 1
- Co-authors
- P. R. SomasundaramSrikanth TripathyC. V. RamakrishnanWallace FoxS. VeluS. DevadattaS. RadhakrishnaT Santha
- Journals
- Lung India (1 paper)Tubercle and Lung Disease (1 paper)PubMed (3 papers)
- Partner nations
- India
In The Last Decade
B. Janardhanam
8 papers receiving 265 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 232
- Pharmacology 93
- Epidemiology 175
- Hepatology 24
- Surgery 86
Countries citing papers authored by B. Janardhanam
This map shows the geographic impact of B. Janardhanam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Janardhanam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Janardhanam more than expected).
Fields of papers citing papers by B. Janardhanam
This network shows the impact of papers produced by B. Janardhanam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Janardhanam. The network helps show where B. Janardhanam may publish in the future.
Co-authorship network
The 24 scholars most cited alongside B. Janardhanam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 14 | |
| 2 | 1989 | 21 | |
| 3 | 1986 | 117 | |
| 4 | Arthralgia in South Indian patients with pulmonary tuberculosis during treatment with pyrazinamide and rifampicin | 1984 | 0 |
| 5 | Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone. | 1970 | 35 |
| 6 | Toxicity of pyrazinamide, administered once weekly in high dosage, in tuberculous patients. | 1968 | 13 |
| 7 | A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. | 1966 | 103 |
| 8 | 1966 | 18 | |
| 9 | 1963 | 14 |
About B. Janardhanam
B. Janardhanam is a scholar working on Infectious Diseases, Epidemiology and Pharmacology, having authored 9 papers that have together received 335 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Mycobacterium research and diagnosis (3 papers), Biochemical and Molecular Research (2 papers), Cancer therapeutics and mechanisms (1 paper), Infectious Diseases and Tuberculosis (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Infectious Diseases (232 citations), Pharmacology (93 citations) and Epidemiology (175 citations). B. Janardhanam has collaborated with scholars based in India. Frequent co-authors include P. R. Somasundaram, Srikanth Tripathy, C. V. Ramakrishnan, Wallace Fox, S. Velu, S. Devadatta, S. Radhakrishna, T Santha, H Stott and R Parthasarathy. Their work appears in journals such as Lung India, Tubercle and Lung Disease and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.